Anixa biosciences announces presentation on its ovarian cancer car-t therapy at the rivkin center-aacr 15th biennial ovarian cancer research symposium

San jose, calif. , sept. 3, 2024 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today announced that the inventor of its ovarian cancer car-t technology, jose r.

CAR Ratings Summary

CAR Quant Ranking